ABSTRACT
RESUMEN: Objetivo: Evaluar el grado de concordancia entre las prevalencias de trastornos articulares inflamatorios (TAI) de las Articulaciones Temporomandibulares (ATM), obtenidas con los Criterios Diagnósticos de Investigación para Trastornos Temporomandibulares (RDC/TMD) y los Criterios Diagnósticos para Trastornos Temporomandibulares (DC/TMD). Materiales y métodos: 59 pacientes adultos chilenos fueron examinados según el Eje I de los RDC/TMD y el Eje I de los DC/TMD para determinar la prevalencia de TAI. Luego se compararon los resultados obtenidos de cada protocolo con el test Kappa de Cohen para evaluar la concordancia entre ambos. Resultados: La prevalencia de TAI para ambos criterios fue de 22%, con una concordancia casi perfecta (kappa=0,91). Al comparar las prevalencias de TAI por articulación, se obtuvo un grado de acuerdo sustancial (kappa=0,77) para la ATM derecha y un grado de acuerdo casi perfecto (kappa=0,94) para la ATM izquierda. Al comparar las prevalencias de TAI según género y edad se obtuvo una concordancia estadísticamente significativa en la mayoría de los casos. Conclusión: Hay concordancia estadísticamente significativa entre los datos obtenidos con los RDC/TMD y los DC/TMD, en el diagnóstico de trastornos articulares inflamatorios.
ABSTRACT: Aim: To assess the agreement between the prevalence of inflammatory joint disorders (IJD) obtained with Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) and Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). Materials and methods: 59 Chilean adult patients were examined according to Axis I of the RDC/TMD and Axis I of the DC/TMD to determine prevalence of IJD. Then, the results obtained from each protocol were compared with Cohen's Kappa test to assess the agreement between them. Results: The prevalence of IJD for both criteria was 22%, with almost perfect agreement (kappa = 0.91). When comparing the prevalences of IJD per joint, a substantial agreement (kappa = 0.77) was obtained for the right TMJ and an almost perfect agreement (kappa = 0.94) for the left TMJ. When comparing the prevalences of IJD according to gender and age, a statistically significant agreement was obtained in the majority of cases. Conclusion: There is statistically significant agreement between the data obtained with the RDC/TMD and the DC/TMD, in the diagnosis of inflammatory joint disorders.
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Temporomandibular Joint , Dentistry , Diagnosis , Epidemiology, Descriptive , Cross-Sectional StudiesABSTRACT
Objetivo Determinar los cambios en calidad de vida en mujeres sometidas a mamoplastia de aumento o mastopexia con prótesis, usando el instrumento validado Breast-Q®. Materiales y métodos Estudio de cohortes prospectivo. Se incluyeron todas las pacientes operadas de mamoplastia de aumento o mastopexia de aumento en el Hospital Clínico de la Universidad de Chile entre octubre de 2013 y mayo de 2014. La calidad de vida (CdV) se midió con el instrumento validado Breast-Q®. Se realizó estadística descriptiva y analítica para evaluar el cambio global en CdV y por dominios considerando estadísticamente significativo un valor p < 0,05. Resultados En el periodo estudiado se operaron 58 pacientes, 33 (56,9%) completaron el instrumento Breast-Q® en el preoperatorio y 25 (75,7%) de ellas en el postoperatorio. La CdV subió de un 49,7% a un 82,5% (p < 0,001); analizando por dominio hubo mejoría en autoestima (52% a 88%, p < 0,001), autoimagen (22% a 80%, p < 0,001) y vida sexual (31% a 86%, p < 0,001). Los síntomas físicos empeoraron desde un 94% a 75% (p < 0,001). Conclusiones El aumento mamario mejora la CdV, específicamente la autoestima, la autoimagen y la vida sexual, pero las molestias físicas aumentan. La satisfacción global fue alta.
Objective To determine the changes in the quality of life of women subjected to augmentation mammoplasty or a prosthesis mastopexy, using the validated tool Breast-Q®. Materials and methods A prospective cohorts study was conducted that included operated on for augmentation mammoplasty or augmentation mastopexy in the Hospital Clínico de la Universidad de Chile (HCUCH) between October 2013 and May 2014. The quality of life (QoL) was measured using the Breast-Q® validated tool. Descriptive and analytic statistics were performed to evaluate the overall change in QoL and by domains, considering a p<.05 as statistically significant. Results A total of 58 patients were operated on, of whom 33 (56.9%) completed the Breast-Q® questionnaire before surgery, and 25 (75.7%) of them in the post-operative period. The quality of life increased from 49.7% to 82.5% (p<.001). When analysed by domain, there was an improvement in Self-esteem (52% to 88%, p<.001), Self-image (22% to 80%, p<.001) and Sex Life (31% to 86%, p<.001). The physical symptoms increased from 75% to 94% (p<.001). Conclusions Breast augmentation improves the quality of life, in particular, self-esteem, self-image, and sex life, but physical discomforts increased. The overall satisfaction was high.
Subject(s)
Humans , Female , Adolescent , Adult , Middle Aged , Quality of Life , Breast Implants/psychology , Breast Implantation/psychology , Self Concept , Activities of Daily Living/psychology , Prospective Studies , Surveys and Questionnaires , Follow-Up Studies , Patient SatisfactionABSTRACT
BACKGROUND: The purpose of this study was to determine whether suction-assisted lipectomy (SAL) decreases the incidence of early cardiovascular disease risk factors or its biochemical and clinical risk indicators. METHODS: A systematic review of the literature was performed by conducting a predefined, sensitive search in MEDLINE without limiting the year of publication or language. The extracted data included the basal characteristics of the patients, the surgical technique, the amount of fat extracted, the cardiovascular risk factors and the biochemical and clinical markers monitored over time. The data were analysed using pooled curves, risk ratios and standardised means with meta-analytical techniques. RESULTS: Fifteen studies were identified involving 357 patients. In all of the studies, measurements of predefined variables were recorded before and after the SAL procedure. The median follow-up was 3 months (interquartile range (IQR) 1-6, range 0.5-10.5). The mean amount of extracted fat ranged from 2063 to 16,300 ml, with a mean ± standard deviation (SD) of 6138 ± 4735 ml. After adjusting for time and body mass index (BMI), leptin and fasting insulin were the only markers that were significantly associated with the amount of aspirated fat. No associations were observed for high sensitive C-reactive protein (hCRP), interleukin-6 (IL-6), adiponectin, resistin, tumour necrosis factor-α (TNF-α), Homeostasis Model of Assessment (HOMA), total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides, free fatty acids or systolic blood pressure. CONCLUSIONS: Based on the results of our analysis, we conclude that there is no evidence to support the hypothesis that subcutaneous fat removal reduces early cardiovascular or metabolic disease, its markers or its risk factors.
